Duriye Damla Sevgi

Dr. Duriye Damla Sevgi

Indiana University School of Medicine
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2017 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
SDSamaneh Davoudi
Samaneh Davoudi
NENazanin Ebrahimiadib
Nazanin Ebrahimiadib
CYCagla Yasa
Cagla Yasa
DSDuriye Damla Sevgi
Duriye Damla Sevgi
RRRamak Roohipoor
Ramak Roohipoor
LSLucia Sobrin
Lucia Sobrin

Verified
Journal Article
Open access
PDF file
Gagan KalraGagan Kalra
Gagan Kalra
SKSudeshna Sil Kar
Sudeshna Sil Kar
DSDuriye Damla Sevgi
Duriye Damla Sevgi
Anant MadabhushiAnant Madabhushi
Anant Madabhushi
SSSunil K. Srivastava
Sunil K. Srivastava
Justis P. EhlersJustis P. Ehlers
Justis P. Ehlers
The management of retinal diseases relies heavily on digital imaging data, including optical coherence tomography (OCT) and fluorescein angiography (FA). Targeted feature extraction and the objective quantification of features provide important opportunities in biomarker discovery, disease burden assessment, and predicting treatment response. Additional important advantages include increased objectivity in interpretation, longitudinal tracking, and ability to incorporate computational models to create automated diagnostic and clinical decision support systems. Advances in computational technology, including deep learning and radiomics, open new doors for developing an imaging phenotype that may provide in-depth personalized disease characterization and enhance opportunities in precision medicine. In this review, we summarize current quantitative and radiomic imaging biomarkers described in the literature for age-related macular degeneration and diabetic eye disease using imaging modalities such as OCT, FA, and OCT angiography (OCTA). Various approaches used to identify and extract these biomarkers that utilize artificial intelligence and deep learning are also summarized in this review. These quantifiable biomarkers and automated approaches have unleashed new frontiers of personalized medicine where treatments are tailored, based on patient-specific longitudinally trackable biomarkers, and response monitoring can be achieved with a high degree of accuracy.

19 August 2020 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
PPPrateek Prasanna
Prateek Prasanna
VBVishal Bobba
Vishal Bobba
NFNatalia Figueiredo
Natalia Figueiredo
DSDuriye Damla Sevgi
Duriye Damla Sevgi
CLCheng Lu
Cheng Lu
Justis P. EhlersJustis P. Ehlers
Justis P. Ehlers
Aim To evaluate the potential of radiomics-based ultra-widefield fluorescein angiography (UWFA)-derived imaging biomarkers in retinal vascular disease for predicting therapeutic durability of intravitreal aflibercept injection (IAI). Methods The Peripheral and Macular Retinal Vascular Perfusion and Leakage Dynamics in Diabetic Macular Edema and Retinal Venous Occlusions During Intravitreal Aflibercept Injection (IAI) Treatment for Retinal Edema (PERMEATE) study prospectively evaluated quantitative UWFA dynamics in diabetic macular oedema or macular oedema secondary to retinal vascular occlusion. 27 treatment-naïve eyes were treated with 2 mg IAI q4 weeks for the first 6 months, and then administered q8 weeks. Morphological and graph-based attributes were used to model the spatial distribution of leakage areas, while tortuosity measures were used to model the vessel network disorder. Eyes were grouped based on functional tolerance of the first 8-week treatment interval challenge. ‘Non-rebounders’ (N=15) maintained/improved best-corrected visual acuity (BCVA) following the 8-week challenge. ‘Rebounders’ (N=12) exhibited worsened BVCA. The image biomarkers were used with a machine learning classifier to preliminarily evaluate their ability to predict BCVA stability. Results Two new UWFA image-derived biomarkers were identified and extracted. The cross-validated area under the receiver operating characteristic curve (AUC) was 0.77±0.14 using baseline leakage distribution features and 0.73±0.10 for the UWFA baseline tortuosity measures. Additionally, the change in vascular tortuosity between month 4 and baseline yielded an AUC of 0.73±0.08. Three baseline clinical features of letter score, macular volume and central subfield thickness yielded a corresponding AUC of 0.42±0.09. Conclusions Two computer-extracted UWFA radiomics-based descriptors were identified as potential biomarkers for predicting treatment durability and tolerance of longer treatment intervals. Conventional treatment parameters were not significantly different between these same groups.

18 May 2017 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
DSDuriye Damla Sevgi
Duriye Damla Sevgi
SDSamaneh Davoudi
Samaneh Davoudi
JCJason Comander
Jason Comander
LSLucia Sobrin
Lucia Sobrin

1 June 2021 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
HYHannah Yu
Hannah Yu
Justis P. EhlersJustis P. Ehlers
Justis P. Ehlers
DSDuriye Damla Sevgi
Duriye Damla Sevgi
JHJenna Hach
Jenna Hach
MOMargaret O'COnnell
Margaret O'COnnell
CWCharles Wykoff
Charles Wykoff

1 February 2016 in Digital Journal of Ophthalmology
Verified
Journal Article
Open access
DSDuriye Damla Sevgi
Duriye Damla Sevgi
LSLucia Sobrin
Lucia Sobrin
GPGeorge N. Papaliodis
George N. Papaliodis
Cogan syndrome is a rare disease characterized by coexisting audiovestibular and ocular symptoms. Almost half of patients develop systemic manifestations. We report the case of a 38-year-old woman who presented with severe medium and large vessel vasculitis as a systemic manifestation of Cogan syndrome.